Zosyn Reaches Blockbuster Status Despite Being Off-Patent

Drug Industry Daily
KEYWORDS Generics / Patents
A A
Wyeth's intravenous antibiotic Zosyn has reached blockbuster status despite not having patent protection, the company announced during its first-quarter earnings call.

To View This Article:

Login

Subscribe To Drug Industry Daily